StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Scynexis's profit margin for the twelve months ending Jun 30, 2026 was -53.3%. For fiscal 2025 it was -41.8%, against -568.3% the year before. The highest annual figure on record is 47.8% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-41.8%+526.5
FY2024Dec 31, 2024-568.3%−616.1
FY2023Dec 31, 202347.8%+1281.6
FY2022Dec 31, 2022-1233.7%−984.0
FY2021Dec 31, 2021-249.7%+44138.7
FY2019Dec 31, 2019-44388.4%−39537.1
FY2018Dec 31, 2018-4851.4%+4899.6
FY2017Dec 31, 2017-9751.0%+1917.9
FY2016Dec 31, 2016-11668.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20263147.7%+5245.3
Q4 FY2025Dec 31, 202565.7%+519.5
Q3 FY2025Sep 30, 2025-2572.2%−2146.7
Q2 FY2025Jun 30, 2025-504.8%+1459.6
Q1 FY2025Mar 31, 2025-2097.7%−2127.6
Q4 FY2024Dec 31, 2024-453.7%−115.9
Q3 FY2024Sep 30, 2024-425.5%−325.7
Q2 FY2024Jun 30, 2024-1964.4%−2057.4
Q1 FY2024Mar 31, 202429.9%+3027.8
Q4 FY2023Dec 31, 2023-337.9%+608.9
Q3 FY2023Sep 30, 2023-99.8%+1800.3
Q2 FY2023Jun 30, 202393.0%+1101.7
Q1 FY2023Mar 31, 2023-2997.9%−2204.4
Q4 FY2022Dec 31, 2022-946.8%+3951.5
Q3 FY2022Sep 30, 2022-1900.1%−1782.8
Q2 FY2022Jun 30, 2022-1008.7%−969.9
Q1 FY2022Mar 31, 2022-793.4%+13948.7
Q4 FY2021Dec 31, 2021-4898.3%+30895.4
Q3 FY2021Sep 30, 2021-117.2%−3151.6
Q1 FY2021Mar 31, 2021-38.8%−587.2
Q2 FY2019Jun 30, 2019-14742.1%+2065.7
Q1 FY2019Mar 31, 2019-35793.8%−29540.6
Q4 FY2018Dec 31, 20183034.4%+14893.8
Q3 FY2018Sep 30, 2018548.4%+13675.0
Q2 FY2018Jun 30, 2018-16807.8%−10246.9
Q1 FY2018Mar 31, 2018-6253.1%+1354.7
Q4 FY2017Dec 31, 2017-11859.4%−6553.2
Q3 FY2017Sep 30, 2017-13126.6%+4417.2
Q2 FY2017Jun 30, 2017-6560.9%–
Q1 FY2017Mar 31, 2017-7607.8%–
Q4 FY2016Dec 31, 2016-5306.2%–
Q3 FY2016Sep 30, 2016-17543.8%–

More Scynexis figures

See a number that looks wrong?